外周促肾上腺皮质激素释放因子触发腹泻型肠易激综合征患者空肠肥大细胞活化与腹痛
研究评估外周促肾上腺皮质激素释放因子(CRF)对腹泻型肠易激综合征(IBS-D)肠道屏障功能的影响,对21例IBS-D和17名健康受试者序贯静脉给予生理盐水(安慰剂)和CRF(100 μg),灌注20 cm空肠段并检测多项指标。结果显示CRF使IBS-D患者水通量显著增加(P=0.007)、白蛋白输出增加(P=0.042)、空肠类胰蛋白酶释放增加且反应高于健康受试者(P=0.0023),腹痛仅IBS-D加重并与类胰蛋白酶释放、水通量和白蛋白输出相关。
要点
- CRF使IBS-D患者空肠水通量显著增加(P=0.007),健康受试者无变化。
- CRF使两组空肠类胰蛋白酶释放均增加(P=0.004),IBS-D反应高于健康受试者(P=0.0023)。
- 腹痛仅在IBS-D患者CRF后加重,并与类胰蛋白酶释放、水通量和白蛋白输出相关。
核心结论
- CRF驱动的肥大细胞活化所介导的应激似乎与IBS-D的病理生理相关。
研究设计与样本
- 在21例IBS-D患者和17名健康受试者中评估序贯静脉给予5 mL生理盐水(安慰剂)和CRF(100 μg)的肠道反应,灌注20 cm空肠段并收集基线、安慰剂后30分钟和CRF后60分钟的流出液。
主要发现
- 安慰剂后IBS-D和健康受试者水通量均无变化,CRF后IBS-D水通量显著增加(P=0.007)。
- IBS-D基础腔内白蛋白输出较高,CRF后IBS-D进一步增加(P=0.042)。
- IBS-D基础空肠类胰蛋白酶释放较高,CRF使两组均显著增加(P=0.004),IBS-D反应高于健康受试者(P=0.0023)。
- CRF后腹痛仅在IBS-D加重,并与空肠类胰蛋白酶释放、水通量和白蛋白输出相关。
- 与健康受试者相比,IBS-D空肠CRF2上调、CRF1下调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: To determine the effect of peripheral CRF on intestinal barrier function in diarrhea-predominant IBS (IBS-D). Irritable bowel syndrome (IBS) pathophysiology has been linked to life stress, epithelial barrier dysfunction, and mast cell activation. Corticotropin-releasing factor (CRF) is a major mediator of stress responses in the gastrointestinal tract, yet its role on IBS mucosal function remains largely unknown. METHODS: Intestinal response to sequential i.v. 5-mL saline solution (placebo) and CRF (100 μg) was evaluated in 21 IBS-D and 17 healthy subjects (HSs). A 20-cm jejunal segment was perfused with an isosmotic solution and effluents collected at baseline, 30 minutes after placebo, and 60 minutes after CRF. We measured water flux, albumin output, tryptase release, stress hormones, cardiovascular and psychological responses, and abdominal pain. A jejunal biopsy was obtained for CRF receptor expression assessment. RESULTS: Water flux did not change after placebo in IBS-D and HS but significantly increased after CRF in IBS-D (P = 0.007). Basal luminal output of albumin was higher in IBS-D and increased further after CRF in IBS-D (P = 0.042). Basal jejunal tryptase release was higher in IBS-D, and CRF significantly increased it in both groups (P = 0.004), the response being higher in IBS-D than in HS (P = 0.0023). Abdominal pain worsened only in IBS-D after CRF and correlated with jejunal tryptase release, water flux, and albumin output. IBS-D displayed jejunal up-regulation of CRF2 and down-regulation of CRF1 compared with HS. DISCUSSION: Stress via CRF-driven mast cell activation seems to be relevant in the pathophysiology of IBS-D.
引用
- Guilarte M, Vicario M, Martínez C, et al. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Am J Gastroenterol. 2020. PMID: 32740086. doi:10.14309/ajg.0000000000000789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。